jueves, 18 de junio de 2020

NIH: National Institute of Allergy and Infectious Diseases | Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases

NIH: National Institute of Allergy and Infectious Diseases | Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases

NIH/NIAID Template Banner



June 17, 2020 NIAID Funding News

Feature Articles 

June Advisory Council Meeting—A Virtual Reality

NIAID Director Dr. Anthony Fauci and Vaccine Research Center Director Dr. John Mascola provided remarks on the Institute's research response to COVID-19 at the 195th NIAID Advisory Council meeting.

Opportunities and Resources

Help us develop innovative strategies to cure or achieve sustained remission of persistent HIV infection through two new cooperative agreement funding opportunity announcements.
Learn how you can help enhance the diversity of the research workforce by recruiting and supporting students, postdocs, and other eligible investigators from diverse backgrounds to work on existing projects.

In The News

We’d like to sincerely thank everyone who has volunteered to serve on our review panels for expedited review of grant applications and contract proposals for research on SARS-CoV-2 and COVID-19.
Attend upcoming webinars designed to help prospective applicants to SARS-CoV-2 serological sciences and high-risk, high-reward research funding opportunities.
The change of reporting periods should reduce administrative burden on investigators who receive support from multiple federal agencies to conduct research with animals.

Advice Corner

NIH now requires formal instruction in rigorous experimental design and transparency to enhance reproducibility for institutional training, individual career development, and individual fellowship applications.

Reader Questions

New Funding Opportunities

  • NIAID Clinical Data and Safety Management Center (CDSMC)
  • PAR-20-231, HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01, Independent Clinical Trial Not Allowed)
  • RFA-AI-20-036, Martin Delaney Collaboratory for Pediatric HIV Cure Research (UM1, Clinical Trial Not Allowed)
  • RFA-AI-20-035, Martin Delaney Collaboratories for HIV Cure Research (UM1, Clinical Trial Not Allowed)
  • NOT-OD-20-119, Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
  • NOT-OD-20-120, Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
  • NOT-OD-20-121, Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
  • PAR-20-229, Global Infectious Disease Research Training Program (D43, Clinical Trial Optional)
  • PA-20-227, Administrative Supplements for Research on Dietary Supplements (Admin Supp, Clinical Trial Not Allowed)
  • Intramural R&D contract - Clinical Trial Materials for Virus Vaccines
  • NOT-AI-20-044, Notice of Special Interest (NOSI)—NIAID Priorities for Biomedical Knowledgebases & Repositories
  • RFA-CA-20-039, Emergency Awards - Research Projects in SARS-CoV-2 Serological Sciences (U01, Clinical Trial Optional)
  • RFA-CA-20-038, Emergency Awards - SARS-CoV-2 Serological Sciences Centers of Excellence (U54, Clinical Trial Optional)
  • NOT-MH-20-048, Notice of Special Interest (NOSI) - Chimerism in Marmosets and other New World Primates
Find other announcements at NIAID Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.

No hay comentarios: